http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104402864-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac31afbea1cbbb03498644721ffb4a62 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2014-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aff9ecce90ad72fa12b16e4397bb5a28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1be8c1052ef4aefc9bbd4b37ed740ec7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d69471d599bcc07ef2039c178ebdac90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8430571dd65611a3115674708737fd97 |
publicationDate | 2015-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104402864-A |
titleOfInvention | Synthesis and Biological Activity Evaluation of a Class of Quinoline-imidazole Derivatives Inhibiting Telomerase Activity |
abstract | A class of synthesis of quinoline imidazole derivatives inhibiting telomerase activity is characterized in that it has the following general formula: R 1 =3a: oF; 3b: mF; 3c: pF; 3d: o-Cl; 3e: m-Cl; 3f: p-Cl; 3g: o-Br; 3h: m-Br; 3i: p-Br 3j: o-NO2; 3k: m-NO2; 3l: p-NO2; 3m: o-CH3; 3n: m-CH3; 3o: p-CH3 ; 3p : o - OCH3 ; 3q: m-OCH 3 ; 3r: p-OCH 3 ; 3s: 2-Cl-4-Cl; 3t: 2-F-4-Cl; 3u: fused Ph; 3v: p-NC 2 H 6 ; H. The present invention discloses its preparation method. |
priorityDate | 2014-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103588758-A |
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465366115 |
Total number of triples: 17.